Judge Won’t Decertify Namenda Antitrust Class Action Month Before Trial
NEW YORK — A New York federal judge denied a motion by two drug makers to decertify an antitrust class action for indirect purchasers of the Alzheimer’s drug Namenda (memantine) ahead...To view the full article, register now.
Already a subscriber? Click here to view full article